The FDA is issuing this update to alert health care providers of five reports of unanticipated deaths that occurred from 2016 to present in patients with liquid-filled intragastric balloon systems used to treat obesity.
Read more: UPDATE: Potential risks with liquid-filled intragastric balloons - Letter to Health Care Providers